Bayer introduces OTC back pain device

Bayer introduces OTC back pain device

alevetherapy_1
German multinational pharmaeuutical company has a drug-free, device for fhe management of pain.
The device, Aleve Direct Therapy, uses transcutaneous electrical nerve stimulation (TENS), which delivers stimulating pulses to the pain site. TENS is typically used by doctors to help relieve lower back pain.
No prescription is needed for the device, which can be used for temporary relief of muscular pain in the lower back due to strain, exercise or even normal day-to-day activities.
According to Bayer’s announcement, the theory behind the therapy is that it blocks pain signals and in turn releases endorphins in the affected area.The device is operated with a wireless remote that controls the waveform technology.
The company says the device can be worn discreetly throughout the day and during some physical activities. Users go through a three-stage therapy session that can be repeated as necessary, with 30-minute breaks between sessions.
The first stage, during which high-frequency stimulation first initiates pain suppression, lasts 5 minutes. A 20-minute second stage offers low-frequency stimulation to increase the release of endorphins. The final stage lasts an additional 5 minutes and offers the same high-frequency stimulation as stage one, to maintain the feeling of pain relief.
“Aleve Direct Therapy puts controllable TENS technology in consumers’ hands without having to visit the doctor,” said Andre Schmidt, vice president of U.S. medical affairs for Bayer’s consumer health division, in the announcement.
“It provides high intensity of power and its wireless remote control makes it easy to adjust the power of intensity to fit the user’s needs.” The device is regulated as a Class II medical device and was cleared by the FDA.

About author

You might also like

Lagos Health Commissioner, Special Adviser assume duties

Seek support, collaboration of stakeholders  The newly sworn-in Lagos State Commissioner for Health, Prof. Akin Abayomi, and the Special Adviser to the Governor on Health, Dr. Oreoluwa Finnih-Awokoya yesterday assumed

Zambia dismisses reports of Ebola outbreak in capital

Health authorities in Zambia on Tuesday September 4, dismissed reports that the country has recorded its first Ebola case. Reports in some local media reported that the country recorded its

PSN worries over rate of members leaving Nigeria 

The Pharmaceutical Society of Nigeria, (PSN), has expressed worry over the rate its members are leaving the country for greener pastures. Chairman of the association, Osun State chapter, Prof Moses

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply